We are live on
!
Find out more
FIM
Fernwood Investment Management Portfolio holdings
AUM
$288M
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+21.24%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$187M
AUM Growth
+$32.2M
(+21%)
Cap. Flow
+$4.96M
Cap. Flow
% of AUM
2.65%
Top 10 Holdings %
Top 10 Hldgs %
33.98%
Holding
159
New
14
Increased
42
Reduced
53
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$1.35M |
| 2 |
iShares Core Dividend Growth ETF
DGRO
|
+$652K |
| 3 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$646K |
| 4 |
DAY
Dayforce
DAY
|
+$483K |
| 5 |
Amazon
AMZN
|
+$404K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$1.59M |
| 2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$954K |
| 3 |
NFX
Newfield Exploration
NFX
|
+$405K |
| 4 |
Tractor Supply
TSCO
|
+$245K |
| 5 |
Cigna
CI
|
+$214K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.05% |
| 2 | Energy | 7.64% |
| 3 | Technology | 7.07% |
| 4 | Consumer Discretionary | 6.45% |
| 5 | Consumer Staples | 5.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCXI
151
DELISTED
ChemoCentryx, Inc.
CCXI
| $139K | 0.07% |
10,000
| – | – |
|
|
FOMX
152
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $128K | 0.07% |
34,000
| – | – |
|
153
Antero Resources
AR
$11.6B
| $111K | 0.06% |
12,600
| – | – |
|
154
Invesco Senior Income Trust
VVR
$460M
| $86K | 0.05% |
20,500
-2,000
| -9% | -$8.25K |
|
|
DHF
155
BNY Mellon High Yield Strategies Fund
DHF
$175M
| $80K | 0.04% |
25,900
| – | – |
|
|
156
Cigna
CI
$72.4B
| – | – |
-1,125
| Closed | -$214K |
|
157
iShares MSCI Germany ETF
EWG
$1.68B
| – | – |
-8,340
| Closed | -$211K |
|
158
Procter & Gamble
PG
$338B
| – | – |
-2,194
| Closed | -$202K |
|
|
NFX
159
DELISTED
Newfield Exploration
NFX
| – | – |
-27,600
| Closed | -$405K |
|
Similar funds
CIM
CSWM
WWP
GWM
FWM
MWS
AP
AA
Fernwood Investment Management's Q1 2019 Portfolio in Review
As of Q1 2019, Fernwood Investment Management held 159 positions worth $187M, up 21% from $155M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Fernwood Investment Management's Q1 2019 filing shows 14 new, 42 increased, 53 reduced and 4 closed positions. Its largest new stake was Wells Fargo 7.5% Non Cumv Perp Conv: 500 shares worth $646K. The largest sale was Global Blood Therapeutics, Inc., an estimated $1.59M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 29% a quarter earlier, followed by Energy and Technology.
- Fernwood Investment Management's largest Q1 2019 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 500 shares worth $646K.
- Fernwood Investment Management added most to Portola Pharmaceuticals, Inc. in Q1 2019, an estimated $1.35M increase.
- Fernwood Investment Management's biggest Q1 2019 reduction was Global Blood Therapeutics, Inc., cutting an estimated $1.59M.
- Fernwood Investment Management fully exited Newfield Exploration in Q1 2019, selling an estimated $405K.
- Fernwood Investment Management's ten largest holdings make up 34% of its $187M portfolio in Q1 2019.
- Fernwood Investment Management opened 14 new positions and closed 4 in Q1 2019.
- Fernwood Investment Management's portfolio value rose 21% quarter-over-quarter to $187M.
Based on Fernwood Investment Management's 13F filing for Q1 2019, filed 6 May 2019.